CDK4 and melanoma: Mutational analyses performed by our group in Greek patients with sporadic and genetically enriched melanoma, found a higher prevalence of CDKN2A/CDK4 mutations than previously reported, suggesting a more prominent role of genetic susceptibility to melanoma in regions with a relatively low incidence of melanoma [28]–[29].